Cardiotoxicities of interleukin-2 (IL-2): the nursing challenge.
Sargent
C A
CA
Johns Hopkins Oncology Center, Baltimore, MD.
Shelton
B N
BN
D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D009730:Nursing Assessment
D007376:Interleukin-2